Baxter (BAX) Tops Q3 EPS by 6c, Revenues Beat; Offers FY18 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. USO
7. STZ
8. AAPL
9. SPY
10. APLD

Go back to Baxter (BAX) Tops Q3 EPS by 6c, Revenues Beat; Offers FY18 EPS Outlook

Baxter (BAX) Receives CE Mark for PrisMax

October 29, 2018 7:12 AM EDT

Baxter International Inc. (NYSE: BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the companys next-generation technology for continuous renal replacement and organ support therapies. Designed with input from more than 650 healthcare practitioners around the world, the PrisMax system features innovative technology to make delivering therapy simpler and more efficient while also improving treatment accuracy in the ICU. Baxter kicked off the launch of the PrisMax system at the 2018 European Society... More